GE Healthcare has released two cardiac imaging analysis software technologies, CardiacVX and MR VesselIQ Xpress.
CardiacVX provides semi-automatic analysis of cardiac parameters and allows the user to create a cardiac patient report within the clinical workflow. Recently FDA 510(k) cleared, CardiacVX runs on GE’s Advantage Workstation, providing tools for reviewing and reporting. These include left ventricle segmentation and volumetric functional analysis, myocardial infarct evaluation, flow analysis, time-course analysis, iron-overload assessment and patent foramen ovale assessment.
MR VesselIQ Xpress, built based on GE’s CT VesselIQ Xpress platform, is an image analysis package for MR angiographic data to analyze selected vessels for stenosis, directional tortuosity and other vascular anomalies. MR VesselIQ Xpress provides automatic vessel tracking with centerline display of cardiac vessels, 3D visualization and access to vessel cross section and profile images. The software provides size, stenosis and length measurements of abnormal anatomical structures with two deposited points. Measurement tables and associated images are captured and ready to be included in reports, GE said.